In vitro metabolism of diarylpyrazoles, a novel group of cannabinoid receptor ligands

Drug Metabolism and Disposition

Volumn 33, Issue 4, 2005, Pages 508-517

  Zhang, Qiang ^a   Ma, Peng ^a   Wang, Weiqun ^b   Cole, Richard B ^b   Wang, Guangdi ^a  

^a XAVIER UNIVERSITY OF LOUISIANA   (United States)

^b UNIVERSITY OF NEW ORLEANS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AFFECTING AGENT; LIGAND; PYRAZOLE DERIVATIVE; RIMONABANT;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CHEMICAL BOND; CONTROLLED STUDY; DEHYDRATION; DRUG HYDROXYLATION; DRUG METABOLISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; ISOMER; LIVER MICROSOME; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; ULTRAVIOLET SPECTROSCOPY;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MICROSOMES, LIVER; MORPHOLINES; PIPERIDINES; PYRAZOLES; RATS; RECEPTORS, CANNABINOID;

EID: 15344344375     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.104.001974     Document Type: Article

References (22)

1. Bell MR, D'Ambra TE, Kumar V, Eissenstat MA, and Hermann JL (1991) Antinociceptive (aminoalkyl)-indoles. J Med Chem 34:1099-1110.
2. Bouaboula M, Dussossoy D, and Casellas P (1999) Regulation of peripheral cannabinoid receptor CB2 phosphorylation by the inverse agonist SR144528. J Biol Chem 274:20397-20405.
3. Compton DR, Rice KC, De Costa BR, Razdan RK, Melvin LS, Johnson MR, and Martin BR (1993) Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J Pharmacol Exp Ther 265:218-226.
4. Cosenza M, Gifford AN, Gatley SJ, Pyatt B, Liu Q, Makriyannis A, and Volkow ND (2000) Locomotor activity and occupancy of brain cannabinoid CB1 receptors by the antagonist/inverse agonist AM281. Synapse 38:477-482.
5. Dutta AK, Sard H, Ryan W, Razdan RK, Compton DR, and Martin BR (1994) The synthesis and pharmacological evaluation of the cannabinoid antagonist SR141716A. Med Chem Res 5:54-62.
6. Felder CC, Joyce KE, Briley EM, Glass M, Mackie KP, Fahey KJ, Cullinan GJ, Hunden DC, Johnson DW, Chaney MO, et al. (1998) LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation. J Pharmacol Exp Ther 284:291-297.
7. Felder CC, Joyce KE, Briley EM, Mansouri J, Mackie K, Blond O, Lai Y, Ma AL, and Mitchell RL (1995) Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol 48:443-450.
8. Gatley SJ, Lan R, Pyatt B, Gifford AN, Volkow ND, and Makriyannis A (1997) Binding of the non-classical cannabinoid CP 55,940 and the diarylpyrazole AM251 to rodent brain cannabinoid receptors. Life Sci 61:PL 191-PL 197.
9. Gatley SJ, Lan R, Volkow ND, Pappas N, King P, Wong CT, Gifford AN, Pyatt B, Dewey SL, and Makriyannis A (1998) Imaging the brain marijuana receptor: development of a radioligand that binds to cannabinoid CB1 receptors in vivo. J Neurochem 70:417-423.
10. Keimowitz AR, Martin BR, Razdan RK, Crocker PJ, Mascarella SW, and Thomas BF (2000) QSAR analysis of Delta 8-THC analogues: relationship of side-chain conformation to cannabinoid receptor affinity and pharmacological potency. J Med Chem 43:59-70.
11. Lan R, Liu Q, Fan P, Lin S, Fernando SR, McCallion D, Pertwee R, and Makriyannis A (1999) Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J Med Chem 42:769-776.
12. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, and Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature (Lond) 346:561-564.
13. Munro S, Thomas KL, and Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature (Lond) 365:61-65.
14. Portier M, Rinaldi-Carmona M, Pecceu F, Combes T, Poinot-Chazel C, Calandra B, Barth F, Le Fur G, and Casellas P (1999) SR144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist. J Pharmacol Exp Ther 288:582-589.
15. Razdan RK (1986) Structure-activity relationships in cannabinoids. Pharm Rev 38:75-149.
16. Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Neliat G, Caput D, et al. (1994) SR141719A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244.
17. Sai K, Kaniwa N, Ozawa S, and Sawada J (2001) A new metabolite of irinotecan in which formation is mediated by human hepatic cytochrome P-450 3a4. Drug Metab Dispos 29:1505-1513.
18. Shim JY, Collantes ER, Welsh WJ, Subramaniam B, Howlett AC, Eissenstat MA, and Ward SJ (1998) Three-dimensional quantitative structure-activity relationship study of the cannabimimetic (aminoalkyl)indoles using comparative molecular field analysis. J Med Chem 41:4521-4532.
19. Showalter VM, Compton DR, Martin BR, and Abood ME (1996) Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J Pharmacol Exp Ther 278:989-999.
20. Wiley JL, Jefferson RG, Grier MC, Mahadevan A, Razdan RK, and Martin BR (2001) Novel pyrozole cannabinoids: insights into CB1 receptor recognition and activation. J Pharmacol Ex Ther 296:1013-1022.
21. Zhang Q, Ma P, Iszard M, Cole RB, Wang W, and Wang G (2002) In vitro metabolism of R(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3- de]1,4-benzoxazinyl]-(1-naphthalenyl) methanone mesylate, a cannabinoid receptor agonist. Drug Metab Dispos 30:1077-1086.
22. Zhang Q, Ma P, Wang W, Cole RB, and Wang G (2004) Characterization of rat liver microsomal metabolites of AM-630, a potent cannabinoid receptor antagonist, by high performance liquid chromatography/electrospray ionization tandem mass spectrometry. J Mass Spectrom 39:672-681.